Combination capecitabine and bevacizumab in the treatment of metastatic hepatic epithelioid hemangioendothelioma

Therapeutic Advances in Medical Oncology

Volumn 7, Issue 4, 2015, Pages 229-236

  Lau, Augustine ^a   Malangone, Steve ^b   Green, Myke ^b   Clarke, Kathryn ^b   Badari, Ambuga ^c   Elquza, Emad ^d  

^a Yuma Regional Cancer Center   (United Kingdom)

^b UNIVERSITY OF ARIZONA   (United States)

^c Yuma Regional Medical Center   (United States)

^d UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Bevacizumab; Capecitabine; Epithelioid; Hemangioendothelioma; Heptatic; Metastatic

Indexed keywords

BEVACIZUMAB; CAPECITABINE; CARBOPLATIN; CARCINOEMBRYONIC ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; CYTOKERATIN 20; CYTOKERATIN 7; CYTOKERATIN 8; GEMCITABINE; PACLITAXEL; SORAFENIB;

ADD ON THERAPY; ADULT; BILE DUCT CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DRUG WITHDRAWAL; FEMALE; HEMANGIOENDOTHELIOMA; HEPATIC EPITHELIOID HEMANGIOENDOTHELIOMA; HEPATOCHOLANGIOMA; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER FIBROSIS; LIVER TRANSPLANTATION; LIVER TUMOR; LUNG NODULE; MEDICAL HISTORY; MIDDLE AGED; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; TOBACCO USE; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; WHEEZING;

EID: 84931475651     PISSN: 17588340     EISSN: 17588359     Source Type: Journal    
DOI: 10.1177/1758834015582206     Document Type: Review

References (46)

1. Agulnik M. Yarber J. Okuno S. von Mehren M. Jovanovic B. Brockstein B. et al. (2013) An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas. Ann Oncol 24: 257–263.
2. Al-Shraim M. Mahboub B. Neligan P. Chamberlain D. Ghazarian D. (2005) Primary pleural epithelioid haemangioendothelioma with metastases to the skin. A case report and literature review. J Clin Pathol 58: 107–109.
3. Amin S. Chung H. Jha R. (2011) Hepatic epithelioid hemangioendothelioma: MR imaging findings. Abdom Imaging 36: 407–414.
4. Belmont L. Zemoura L. Couderc L. (2008) Pulmonary epithelioid haemangioendothelioma and bevacizumab. J Thorac Oncol 3: 557–558.
5. Bolke E. Gripp S. Peiper M. Budach W. Schwartz A. Orth K. et al. (2006) Multifocal epithelioid hemangioendothelioma: case report of a clinical chamaeleon. Eur J Med Res 11: 462–466.
6. Calabro L. Di Giacomo A. Altomonte M. Fonsatti E. Mazzel M. Volterrani L. et al. (2007) Primary hepatic epithelioid hemangioendothelioma progressively responsive to interferon-alpha: is there room for novel anti-angiogenetic treatments? J Exp Clin Cancer Res 26: 145–150.
7. Cardinal J. de Vera M. March J. Steel J. Geller D. Fontes P. et al. (2009) Treatment of hepatic epithelioid hemangioendothelioma: a single-institution experience with 25 cases. Arch Surg 144: 1035–1039.
8. Coppo P. Lassoued S. Billey T. Lassoued K. (2005) Successful treatment of osteolytic epithelioid hemangioendothelioma with pamidronate. Clin Exp Rheumatol 23: 400–401.
9. Cronin P. Arenberg D. (2004) Pulmonary Epithelioid Hemangioendothelioma: an unusual case and a review of the literature. Chest 125: 789–793.
10. Emamaullee J. Edgar R. Toso C. Thiesen A. Bain V. Bigam D. et al. (2010) Vascular endothelial growth factor expression in hepatic epithelioid hemangioendothelioma: Implications for treatment and surgical management. Liver Transpl 16: 191–197.
11. Errani C. Zhang L. Sung Y. Hajdu M. Singer S. Maki R. et al. (2011) A novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites. Genes Chromosomes Cancer 50: 644–653.
12. Gaur S. Torabi A. O'Neill T. (2012) Activity of angiogenesis inhibitors in metastatic epithelioid hemangioendothelioma: a case report. Cancer Biol Med 9: 133–136.
13. Grenader T. Vernea F. Reinus C. Gabizon A. (2011) Malignant epithelioid hemangioendothelioma of the liver successfully treated with pegylated liposomal doxorubicin. J Clin Oncol 29: e722–e724.
14. Grotz T. Nagorney D. Donohue J. Que F. Kendrick M. Farnell M. et al. (2010) Hepatic epithelioid haemangioendothelioma: is transplantation the only treatment option? HPB 12: 546–553.
15. Hassan I. Barth P. Celik I. Hoffmann S. Langer P. Ramaswamy A. et al. (2005) An authentic malignant epithelioid hemangioendothelioma of the thyroid: a case report and review of the literature. Thyroid 15: 1377–1381.
16. Holley M. Cuschieri A. (1989) Epithelioid haemangioendothelioma of the liver: objective response to hepatic intra-arterial 5-FU. Eur J Surg Oncol 15: 73–78.
17. Kassam A. Mandel K. (2008) Metastatic hepatic epithelioid hemangioendothelioma in a teenage girl. J Pediatr Hematol Oncol 30: 550–552.
18. Kayler L. Merion R. Arenas J. Magee J. Campbell D. Rudich S. et al. (2002) Epithelioid hemangioendothelioma of the liver disseminated to the peritoneum treated with liver transplantation and interferon alpha-2B. Transplantation 74: 128–130.
19. Kelly H. O'Neil B. (2005) Response of epithelioid haemangioendothelioma to liposomal doxorubicin. Lancet Oncol 6: 813–815.
20. Kim Y. Mishima M. Miyagawa-Hayashino A. (2010) Treatment of pulmonary epithelioid hemangioendothelioma with bevacizumab. J Thorac Oncol 5: 1107–1108.
21. Lakkis Z. Kim S. Delabrousse E. Jary M. Nguyen T. Mantion G. et al. (2013) Metronomic cyclophosphamide: an alternative treatment for hepatic epithelioid hemangioendothelioma. J Hepatol 58: 1254–1257.
22. Lauffer J. Zimmermann A. Krahenbuhl L. Triller J. Baer H. (1996) Epithelioid hemangioendothelioma of the liver: a rare hepatic tumor. Cancer 78: 2318–2327.
23. Lazarus A. Fuhrer G. Malekiani C. McKay S. Thurber J. (2011) Primary pleural epithelioid hemangioendothelioma (EHE) - two cases and review of the literature. Clin Respir J 5: e1–e5.
24. Makhlouf H. Ishak K. Goodman Z. (1999) Epithelioid hemangioendothelioma of the liver: a clinicopathologic study of 137 cases. Cancer 85: 562–582.
25. Marquez-Medina D. Samme-Perez-Vargas J. Tuset-DerAbrain N. Montero-Fernanadez A. Taberner-Bonastre T. Porcel J. (2011) Pleural epithelioid hemangioendothelioma in an elderly patient. A case report and review of the literature. Lung Cancer 73: 116–119.
26. Marsh Rde W. Walker M. Jacob G. Liu C. (2005) Breast implants as a possible etiology of epithelioid hemangioendothelioma and successful therapy with interferon-α2. Breast J 11: 257–261.
27. Mascarenhas R. Sanghvi A. Friedlander L. Geyer S. Beasley H. van Thiel D. (2005) Thalidomide inhibits the growth and progression of hepatic epithelioid hemangioendothelioma. Oncology 67: 471–475.
28. Mehrabi A. Kashfi A. Fonouni H. Schemmer P. Schmied B. Hallscheidt P. et al. (2006) Primary Malignant Hepatic Epithelioid Hemangioendothelioma. Cancer 107: 2108–2121.
29. Mistry A. Gorden D. Busler J. Coogan A. Kelly B. (2012) Diagnostic and Therapeutic Challenges in Hepatic Epithelioid Hemangioendothelioma. J Gastrointest Canc 43: 521–525.
30. Mizota A. Shitara K. Fukui T. (2011) Bevacizumab chemotherapy for pulmonary epithelioid hemangioendothelioma with severe dyspnea. J Thorac Oncol 6: 651–652.
31. O'Grady J. (2000) Treatment options for other hepatic malignancies. Liver Transpl. 6:S23-S29
32. Pintoffle J. Meisinger I. Mayer F. Horger M. von Weyham C. Kanz L. et al. (2009) Long-term disease stabilization during second-line gemcitabine in a refractory metastatic haemangioendothelioma. Anticancer Drugs 20: 73–74.
33. Radzikowska E. Szczepulska-Wojcik E. Chabowski M. Oniszh K. Langfort R. Roszkowski K. (2008) Pulmonary epithelioid haemangioendothelioma-interferon 2-alpha treatment-case report. Pneumonol Alergol Pol 76: 281–285.
34. Raphael C. Hudson E. Williams L. Lester J. Savage P. (2010) Successful treatment of metastatic hepatic epithelioid hemangioendothelioma with thalidomide: a case report. J Med Case Rep 4: 413–416.
35. Rodriguez J. Becker N. O'Mahony C. Gross J. Atoia T. (2008) Long-term outcomes following liver transplantation for hepatic hemangioendothelioma: the UNOS experience from 1987 to 2005. J Gastrointest Surg 12: 110–116.
36. Salech F. Valderrama S. Nervi B. Rodriguez J. Oksenberg D. Koch A. et al. (2010) Thalidomide for the treatment of hepatic epithelioid hemangioendothelioma: a case report with a long term follow-up. Ann Hepatol 10: 99–102.
37. Saleiro S. Barbosa M. Souto Moura C. Almeida J. Ferreira S. (2008) Epithelioid hemangioendothelioma–a rare pulmonary tumor. Rev Port Pneumol 14: 421–425.
38. Sangro B. Inarrairaegui M. Fernandez-Ros N. (2012) Malignant epithelioid hemangioendothelioma of the liver successfully treated with Sorafenib. Rare Tumors 4: 106–109.
39. Schattenberg T. Kam R. Klopp M. Herpel E. Schnabel P. Mechtersheimer G. et al. (2008) Pulmonary epithelioid hemangioendothelioma: report of three cases. Surg Today 38: 844–849.
40. Schilling G. Schuch G. Panse J. Sterneck C. (2009) Activity of lenalidomide in metastatic hepatic epithelioid hemangioendothelioma (HEH): a case report. J Clin Oncol (Meeting Abstracts) 27(Suppl.): abstract 15S.
41. Sharif K. English M. Ramani P. Alberti D. Otte J. McKiernan P. et al. (2004) Management of hepatic epithelioid haemangio-endothelioma in children: what option? B J Cancer 90: 1498–1501.
42. Sumrall A. Fredericks R. Berthold A. Shumaker G. (2010) Lenalidomide stops progression of multifocal epithelioid hemangioendothelioma including intracranial disease. J Neurooncol 97: 275–277.
43. Thomas R. Aloia T. Truty M. Tseng W. Choi E. Curley S. et al. (2014) Treatment sequencing strategy for hepatic epithelioid hemangioendothelioma. HPB 16: 677–685.
44. Trautmann K. Bethke A. Ehninger G. Folprecht G. (2011) Bevacizumab for recurrent hemangioendothelioma. Acta Oncol 50: 153–154.
45. Wicki A. Christifori G. (2007) The potential role of podoplanin in tumour invasion. Br J Cancer 96: 1–5.
46. Woelfel C. Liehr T. Weise A. Langrehr J. Kotb W. Pancyna-Gengelbach M. et al. (2011) Molecular cytogenetic characterization of epithelioid hemangioendothelioma. Br J Cancer 204: 671–676.